Tag Archives: randomization in clinical trial

Webinar on Best practices on INTERACTIVE RESPONSE TECHNOLOGY (IRT) and Clinical Supplies Management


What exactly is an IRT system, why is it important in clinical trial, What does your Management demand and what do the IRT providers promise? These are the question the sponsors and clinical trial supply companies faces frequently. DDi is organizing this webinar focusing on the best  practices of the IRT systems and Clinical Supplies. IRT system delivers a wide range of applications for managing patient interactions and drug supplies throughout the trial life-cycle. The process includes Patient randomization, Product inventory management, Patient tracking,Study reporting, Drug accountability and reconciliation.But too often challenges arise among the team while  juggling many conflicting priorities. With a little careful preparation, and an efficient internal process, IRT development can be achieved in a streamlined fashion delivering an optimum IRT system with a fraction of the customary frustration and duplication of effort.

The points which the webinar will be highlighting are:

Appreciating the importance of IRT
Understanding your own organization
An analysis of previous approaches and the implications thereof
Discussion of best practices

Kate Chapman
Former Associate Director, IRT Services,
Shire Pharmaceuticals
Director & Principal Consultant,
Clinical Technology Consultants Ltd.

Priya Kurian
Product Specialist, DDi

About Speaker:

Kate Chapman, the Director of Clinical Technology Consultants Ltd and the Principal Consultant. Clinical Technology Consultants from Winchester,UK, has 19 years of experience in the Clinical Development area of the Pharmaceutical and Biotechnology sector, with a specialization in IRT. Kate has extensive experience as an end-user of IRT systems and continuously reviews many of the systems that are currently available. She worked with companies like Sandoz, Novartis, Innovex, Roche, Bristol Myers Squibb, Sanofi, Merck, Sharpe and Dohme, Pharmacia, PPD and Emergent Biosciences. Kate most recently formed and led an internal support function dedicated to IRT services and associated disciplines for Shire Pharmaceuticals.